NCT04270461 2020-10-22NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid TumorsJiujiang University Affiliated HospitalPhase 1 Withdrawn
NCT01441388 2011-12-20A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors.PfizerPhase 1 Withdrawn